Business
Why the Botanix (ASX:BOT) share price is rocketing 31% higher today
The Botanix Pharmaceuticals Ltd (ASX: BOT) share price has returned from its trading halt with a bang on Wednesday.
In morning trade, the clinical stage synthetic cannabinoid company’s shares are up 31% to a record high of 19 cents.
Why is the Botanix share price rocketing higher?
Investors have been fighting to buy Botanix shares this morning following the release of an announcement in relation to its BTX 1801 Phase 2a nasal decolonisation proof of concept study.
According to the release, top-line data from the study shows that two different BTX 1801 formulations (ointment and gel containing synthetic cannabidiol) were safe, well tolerated, and successful at eradicating Staphylococcus aureus (Staph) bacteria from the nose of…
-
Noosa News20 hours agoBob Katter threatens to punch Nine reporter during ant-immigration press conference
-
Business23 hours agoThis ASX 200 healthcare stock crashed 14% to 4-year low. Here’s what happened
-
Business20 hours agoDicker Data rides the AI trend to double digit growth
-
Noosa News20 hours agoBob Katter threatens Channel 9 journalist for asking question on family heritage